1. FBS or BSA Inhibits EGCG Induced Cell Death through Covalent Binding and the Reduction of Intracellular ROS Production
   Yin Zhang et al, 2016, BioMed Research International CrossRef
2. Epigallocatechin-3-Gallate Ameliorates Angiotensin II-Induced Oxidative Stress and Apoptosis in Human Umbilical Vein Endothelial Cells through the Activation of Nrf2/Caspase-3 Signaling
   Xiuli Zhou et al, 2017, J Vasc Res CrossRef
3. Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis in Ec9706 and Eca109 esophageal carcinoma cells
   Liang Liu et al, 2017 CrossRef
4. TBC2target: A Resource of Predicted Target Genes of Tea Bioactive Compounds
   Shihua Zhang et al, 2018, Front. Plant Sci. CrossRef
5. Resveratrol Ameliorates Microcystin-LR-Induced Testis Germ Cell Apoptosis in Rats via SIRT1 Signaling Pathway Activation
   Haohao Liu et al, 2018, Toxins CrossRef
6. Bioinformatics analysis of microarray profiling identifies the mechanism of focal adhesion kinase signalling pathway in proliferation and apoptosis of breast cancer cells modulated by green tea polyphenol epigallocatechin 3-gallate
   Xiao Luo et al, 2018, J Pharm Pharmacol CrossRef
7. Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
   Emma Bondy-Chorney et al, 2018, Biochem. Cell Biol. CrossRef
8. Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells
   Somaye Mirzaaghaei et al, 2019, ACS Omega CrossRef
9. Wnt/β-catenin pathway mediates (−)-Epigallocatechin-3-gallate (EGCG) inhibition of lung cancer stem cells
   Jianyun Zhu et al, 2017, Biochemical and Biophysical Research Communications CrossRef
10. Inhibition of Nrf2 enhances the anticancer effect of 6-O-angeloylenolin in lung adenocarcinoma
    Yang Wang et al, 2017, Biochemical Pharmacology CrossRef
11. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine.
    Hua Luo et al, 2019, Chin Med CrossRef
12. The prevalence and prognostic value of KRAS co‐mutation subtypes in Chinese advanced non‐small cell lung cancer patients
    Dongjing Cai et al, 2019, Cancer Med CrossRef
13. Tea plant genomics: achievements, challenges and perspectives
    En-Hua Xia et al, 2020, Hortic Res CrossRef
14. Natural Compounds Targeting Cancer Stem Cells: A Promising Resource for Chemotherapy
    Plabon K. Das et al, 2019, ACAMC CrossRef
15. Mapping Pharmacological Network of Multi-Targeting Litchi Ingredients in Cancer Therapeutics
    Sisi Cao et al, 2020, Front. Pharmacol. CrossRef
16. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer
    Saleh A. Almatroodi et al, 2020, Molecules CrossRef
17. Epigallocatechin‑3‑gallate modulates long non‑coding RNA and mRNA expression profiles in lung cancer cells
    Dong‑Li Hu et al, 2019, Mol Med Report CrossRef
18. Acetylation and Deacetylation of DNA Repair Proteins in Cancers
    Shiqin Li et al, 2020, Front. Oncol. CrossRef
19. Tea bioactive components prevent carcinogenesis via anti‐pathogen, anti‐inflammation, and cell survival pathways
    Xiangqi Fan et al, 2021, IUBMB Life CrossRef
20. Gene expression and prognosis of x-ray repair cross-complementing family members in non-small cell lung cancer
    Yongfei Fan et al, 2021, Bioengineered CrossRef
21. LC–MS Based Metabolomics Study of the Effects of EGCG on A549 Cells
    Tingyu Pan et al, 2021, Front. Pharmacol. CrossRef
22. Epigallocatechin 3-Gallate: From Green Tea to Cancer Therapeutics
    Manzar Alam et al, 2022, Food Chemistry CrossRef
23. Targeted Cancer Therapy Based on Acetylation and Deacetylation of Key Proteins Involved in Double-Strand Break Repair
    Xiwen Wang et al, 2022, CMAR CrossRef
24. Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer
    Manzar Alam et al, 2022, Front. Oncol. CrossRef
25. Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?
    Daniela Mokra et al, 2022, Antioxidants CrossRef
26. (‐)‐Epigallocatechin‐3‐gallate induced apoptosis by dissociation of c‐FLIP/Ku70 complex in gastric cancer cells
    Mahtab Shahriari Felordi et al, 2023, J Cellular Molecular Medi CrossRef
27. EGCG: The Antioxidant Powerhouse in Lung Cancer Management and Chemotherapy Enhancement
    Amit Sehgal et al, 2023, Advances in Redox Research CrossRef
28. Herbal Drugs Inducing Autophagy for the Management of Cancer: Mechanism and Utilization
    Shivam Rajput et al, 2024, CPB CrossRef
29. Epigallocatechin gallate protects against fat and muscle atrophy in B16BL6 melanoma-bearing mice on a high-fat diet
    Woo Yong Park et al, 2024, Life Sciences CrossRef
30. Epigallocatechin-3-Gallate Suppresses Vasculogenic Mimicry through Inhibiting the Twist/VE-Cadherin/AKT Pathway in Human Prostate Cancer PC-3 Cells
    Changhwan Yeo et al, 2020, IJMS CrossRef
31. The Potential of Epigallocatechin Gallate in Targeting Cancer Stem Cells: A Comprehensive Review
    Rupa Chaudhuri et al, 2024, CMC CrossRef
32. null
    Mana Alavi et al, 2025 CrossRef